|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.440 CAD | -1.37% |
|
-5.88% | +9.92% |
Company Valuation: Cardiol Therapeutics Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 142 | 43.96 | 71.77 | 151 | 130.4 | 166 | - | - |
| Change | - | -69.05% | 63.28% | 110.34% | -13.65% | 27.33% | - | - |
| Enterprise Value (EV) 1 | 142 | 43.96 | 36.84 | 120.4 | 108.9 | 151 | 155.7 | 166 |
| Change | - | -69.05% | -16.19% | 226.78% | -9.5% | 38.59% | 3.15% | 6.58% |
| P/E | -3.19x | -1.41x | -2.5x | -3.63x | -3.36x | -4x | -6.19x | 39.3x |
| PBR | - | - | 2.55x | 6.18x | 6.41x | 8.18x | 15x | - |
| PEG | - | 0x | 0.2x | -0.2x | 0.1x | 0.52x | 0.2x | -0x |
| Capitalization / Revenue | 1,803x | - | - | - | - | - | 50x | 4.57x |
| EV / Revenue | 1,803x | - | - | - | - | - | 46.9x | 4.57x |
| EV / EBITDA | -4.74x | -1.07x | -1.25x | -3x | -3.18x | -6.41x | -9.8x | -8.05x |
| EV / EBIT | -3.67x | -1.06x | -1.24x | -2.99x | -3.17x | -4.3x | -5.8x | 34.4x |
| EV / FCF | -6.03x | - | -1.46x | -4.8x | -4.56x | -7.44x | -33.3x | - |
| FCF Yield | -16.6% | - | -68.5% | -20.8% | -21.9% | -13.4% | -3.01% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.73 | -0.49 | -0.44 | -0.51 | -0.39 | -0.36 | -0.2325 | 0.0367 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 0.0788 | - | - | - | - | - | 3.321 | 36.32 |
| EBITDA 1 | -29.95 | -41.12 | -29.54 | -40.11 | -34.21 | -23.54 | -15.88 | -20.62 |
| EBIT 1 | -38.66 | -41.34 | -29.79 | -40.28 | -34.32 | -35.09 | -26.87 | 4.821 |
| Net income 1 | -31.64 | -30.93 | -28.13 | -36.68 | -33.82 | -35.21 | -30.57 | -8.68 |
| Net Debt 1 | - | - | -34.93 | -30.58 | -21.42 | -15.01 | -10.26 | - |
| Reference price 2 | 2.330 | 0.690 | 1.100 | 1.850 | 1.310 | 1.440 | 1.440 | 1.440 |
| Nbr of stocks (in thousands) | 60,954 | 63,703 | 65,247 | 81,603 | 99,514 | 1,15,272 | - | - |
| Announcement Date | 23/03/22 | 28/03/23 | 01/04/24 | 31/03/25 | 31/03/26 | - | - | - |
1CAD in Million2CAD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.06x | - | -6.51x | - | 12Cr | |
| 35.02x | 6.15x | 19.02x | 0.94% | 5.04TCr | |
| -23.93x | 350.56x | -22.64x | -.--% | 4.06TCr | |
| 25.43x | 2.81x | 12.14x | -.--% | 3.49TCr | |
| 46.36x | 4.58x | 29.24x | -.--% | 3.37TCr | |
| 26.73x | 7.84x | 19.68x | 0.43% | 2.63TCr | |
| 31.59x | 5.09x | 23.2x | -.--% | 1.53TCr | |
| 23.89x | 2.03x | 8.94x | 1.12% | 1.37TCr | |
| 23.89x | 1.9x | 11.51x | -.--% | 1.29TCr | |
| Average | 20.55x | 47.62x | 10.51x | 0.31% | 2.53TCr | |
| Weighted average by Cap. | 22.21x | 66.45x | 11.36x | 0.32% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CRDL Stock
- Valuation Cardiol Therapeutics Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
